DiscoverClinician's Brief: The PodcastFeline Diabetes: SGLT2 Inhibitor FAQs with Dr. Mott
Feline Diabetes: SGLT2 Inhibitor FAQs with Dr. Mott

Feline Diabetes: SGLT2 Inhibitor FAQs with Dr. Mott

Update: 2024-12-05
Share

Description

When a new drug class enters the veterinary world, first comes the excitement…then comes the learning. In this episode of Clinician’s Brief Partner Podcast, Jocelyn Mott, DVM, DACVIM, answers your most frequently asked questions when it comes to using a novel drug class in the treatment of feline diabetes mellitus: the sodium-glucose cotransporter-2 inhibitor. Tune in as she explains when, how, and why to consider this option in newly diagnosed feline diabetics.

Sponsored by Elanco

Resource:

Contact us:

  • Podcast@briefmedia.com

Where to find us:

The Team:

  • Beth Molleson, DVM - Host
  • Taylor Argo - Producer & Project Manager, Brief Studio
  • Randall Stupka - Podcast Production & Sound Editing
Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Feline Diabetes: SGLT2 Inhibitor FAQs with Dr. Mott

Feline Diabetes: SGLT2 Inhibitor FAQs with Dr. Mott

Brief Media